相关实验视频

Updated: May 29, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

预测甲状腺癌风险的潜在生物标志物在免疫衰老中:基于人口的外部验证的多组研究

Qian Li¹, Yuanyuan Zhao², Jiawei Yan¹

¹Department of Emergency Medicine, Yongchuan Hospital, Chongqing Medical University Affiliated Hospital, Chongqing, China.

Frontiers in oncology

|February 5, 2025

概括

这项研究表明,DNA甲基化加速增长的年龄会增加甲状腺癌的风险. 发现了与衰老和免疫衰变相关的新型血蛋白,为新的诊断和治疗提供了潜力.

科学领域:

整合性奥米克学科
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

全基因组关联研究 (GWAS) 已经确定了甲状腺癌风险位置.
发现与免疫衰变和癌症风险相关的血蛋白仍然具有挑战性.

研究的目的:

识别与免疫衰变和甲状腺癌风险相关的新型血蛋白.
对风险基因和基因的类效应进行研究.
在一个独立的队列中验证发现.

主要方法:

整合性奥米克方法结合了蛋白质组学和转录组学.
对DNA甲基化年龄和甲状腺癌风险的元分析.
大量RNA测序和独立的队列验证.

主要成果:

DNA甲基化年龄加速 (汉纳姆方法) 与增加甲状腺癌风险有关 (OR: 1.126).
后分析发现了138个潜在的风险地点.
发现了六个与免疫衰变和甲状腺癌相关的潜在目标.
在甲状腺癌中,GFRA2和LILRA2表现不同;LILRA2在一个独立的队列中表达高.

结论:

确定了与免疫衰变和甲状腺癌相关的新型血蛋白.
这些发现加深了对免疫衰变与甲状腺癌关系的理解.
结果支持未来诊断和治疗策略的开发.

关键词:

DNA甲基化汉纳姆年龄汉纳姆年龄通过外部验证.生成的遗传风险得分.这是一个元分析.甲状腺癌是一种癌症.

更多相关视频

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...